Siriraj Hospital partners with Cariva to bolster Thailand’s medical AI ecosystem

Siriraj Hospital‘s Faculty of Medicine, under Mahidol University, is partnering with native artificial intelligence (AI) start-up, Cariva (Thailand), to utilise AI expertise in enhancing medical treatment and creating revolutionary medical services and products. This collaboration is aimed at solidifying Thailand’s popularity as a medical hub and facilitating the export of AI-driven healthcare improvements to the Asia-Pacific area.
Dr Apichat Asavamongkolkul, the faculty dean at the hospital, underscored the potential of AI during the memorandum of understanding signed with Cariva. Apichat believes that the combination of AI into their services may help handle a scarcity of physicians, enhance diagnostic accuracy, and enhance medical therapy by offering personalised care. The partnership also envisages nurturing medical AI and medtech start-ups.
Dr Cherdchai Nopmaneejumruslers, the deputy dean for service innovation and organisational values, asserted that the venture would contribute to strengthening the AI medical ecosystem in Thailand. By automating sure tasks, AI can help medical employees who’re burdened with extreme workloads.
The collaboration encompasses 4 initiatives, together with the creation of SiCAR Ai Lab, a platform for testing and developing medical AI. This lab will provide Thai start-ups with the chance to develop extra efficient medical AI, improving health analysis outcomes and reinforcing the medical AI ecosystem.
The second venture entails Mahidol University’s Radiology Department growing RAD Scan AI, capable of studying and analysing photographs corresponding to tumours. This AI, developed by Cariva, can measure the mass of organs and tumours and generate 3D pictures, thus decreasing preparation time for medical employees.
Underground , the CEO and co-founder of Cariva (Thailand) Co, stated that the partnership with Siriraj would help the commercialisation of their product out there. He added that the RAD Scan AI, developed using international data, could be adapted to better go well with the info of local patients.
Another challenge involves the Siriraj Genomics Centre launching new products, including NanoPGx, a nanopore-based pharmacogenomics offering. This high-precision course of can analyse genes with potential for medicine allergic reactions on a population-independent basis, making it suitable for each locals and foreigners.
Lastly, the Center for Value Driven Care (VDC), an R&D centre owned by the faculty, goals to develop innovation and link information from Siriraj medical expertise with new technological advances. This centre can broaden to incorporate AI medical incubation and accelerator programmes.
Cariva, which counts AI and Robotics Ventures Co Ltd (ARV), a subsidiary of PTT Exploration and Production, as an investor, aims to become a unicorn start-up by 2028, reported Bangkok Post.
Follow The Thaiger’s latest tales on our new Facebook page: CLICK HERE..

Leave a Comment